Factors Associated With Adherence to First-line Antiviral Therapy Among Commercially Insured Patients With Chronic Hepatitis B.
Jonathan D AlpernHeesoo JooNathan C BahrThomas M LeventhalPublished in: Open forum infectious diseases (2023)
Ninety-day and mixed-duration supplies of entecavir and TDF were associated with higher fill rates as compared with 30-day supplies among commercially insured patients with CHB.